(ANL) Adlai Nortye American - Performance -54.9% in 12m
ANL performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-53.39%
#74 in Peer-Group
Rel. Strength
8.63%
#6775 in Stock-Universe
Total Return 12m
-54.91%
#137 in Peer-Group
Total Return 5y
-90.20%
#113 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 3.67 USD |
| 52 Week Low | 1.40 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 34.09 |
| Buy/Sell Signal +-5 | -2.86 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ANL (-54.9%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.28% | 31.9% | -4.56% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.02% | 56.7% | -7.85% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.86% | 34.5% | 14.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ANL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ANL
| Total Return (including Dividends) | ANL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -8.70% | 2.09% | 4.55% |
| 3 Months | -26.87% | 2.27% | 10.78% |
| 12 Months | -54.91% | -10.84% | 14.71% |
| 5 Years | -90.20% | -26.24% | 112.53% |
| Trend Score (consistency of price movement) | ANL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -68.6% | 18.8% | 79.2% |
| 3 Months | -82.3% | 71.5% | 92.9% |
| 12 Months | -72% | -84.3% | 44.2% |
| 5 Years | -87.9% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th32.50 | -10.56% | -12.67% |
| 3 Month | %th14.00 | -28.49% | -33.98% |
| 12 Month | %th32.00 | -49.43% | -60.69% |
| 5 Years | %th33.50 | -91.39% | -93.37% |
FAQs
Does Adlai Nortye American (ANL) outperform the market?
No,
over the last 12 months ANL made -54.91%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.84%.
Over the last 3 months ANL made -26.87%, while XBI made 2.27%.
Performance Comparison ANL vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ANL vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2% | -13.3% | -51.3% | -70% |
| US NASDAQ 100 | QQQ | 1.2% | -14.3% | -53.5% | -70% |
| German DAX 40 | DAX | 2.2% | -8.7% | -64.3% | -85% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.4% | -12.9% | -49.3% | -73% |
| Hongkong Hang Seng | HSI | 2.5% | -14.5% | -67.1% | -90% |
| India NIFTY 50 | INDA | 2.5% | -10.8% | -51% | -55% |
| Brasil Bovespa | EWZ | 0.7% | -16.5% | -75.8% | -68% |
ANL vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.5% | -15.5% | -58% | -84% |
| Consumer Discretionary | XLY | 3.6% | -10.3% | -42.6% | -75% |
| Consumer Staples | XLP | 5.5% | -7.1% | -49.5% | -64% |
| Energy | XLE | 6.4% | -12.2% | -45.9% | -51% |
| Financial | XLF | 1.9% | -11.8% | -54.4% | -84% |
| Health Care | XLV | 3% | -10.7% | -44.1% | -50% |
| Industrial | XLI | 2.5% | -12.4% | -57.9% | -79% |
| Materials | XLB | 4% | -10.3% | -50.7% | -58% |
| Real Estate | XLRE | 6.5% | -8.7% | -48.7% | -67% |
| Technology | XLK | 0.7% | -17.6% | -54.5% | -67% |
| Utilities | XLU | 4.5% | -8.8% | -54.7% | -79% |
| Aerospace & Defense | XAR | 0.1% | -18.6% | -72.7% | -108% |
| Biotech | XBI | 4.2% | -10.8% | -37.4% | -44% |
| Homebuilder | XHB | 3.8% | -14.8% | -40% | -56% |
| Retail | XRT | 5.1% | -10.1% | -42.6% | -61% |
ANL vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 9.3% | -13.8% | -42.0% | -45% |
| Natural Gas | UNG | 14.3% | 0.7% | -36.2% | -47% |
| Gold | GLD | 7% | -6.5% | -71.2% | -96% |
| Silver | SLV | 5.5% | -12.6% | -69.9% | -77% |
| Copper | CPER | 1.8% | -12.9% | -71% | -70% |
ANL vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.3% | -12.3% | -48.1% | -57% |
| iShares High Yield Corp. Bond | HYG | 4.1% | -10.6% | -50.3% | -66% |